What I Read This Week...

chamath.substack.com · 362 words · saved by 1 readers

Salesforce stock drops more than 20% after releasing Q2 earnings, investor sentiment is shifting on generative AI, and a new drug offers the possibility of tooth regeneration in humans

Watch All-In E181 Read our latest deep dive into semiconductors Caught My Eye… Salesforce’s share price dropped more than 20% after releasing its Q2 2024 earnings, despite earnings falling just 0.3% below Wall Street analysts' expectations. What's going on? Two factors appear to be responsible for this decline. First, a slowing economy poses a risk to revenues as customers more carefully evaluate the return on investment of Salesforce’s products before committing to a purchase. Second, analysts are concerned that generative AI could help competitors deliver similar functionalities to…

What I Read This Week...

related reading